- Home
- SCWO vs OSTX Comparison
SCWO vs OSTX Comparison
Compare SCWO & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCWO
- OSTX
- Stock Information
- Founded
- SCWO 2021
- OSTX 2018
- Country
- SCWO United States
- OSTX United States
- Employees
- SCWO N/A
- OSTX N/A
- Industry
- SCWO Environmental Services
- OSTX
- Sector
- SCWO Utilities
- OSTX
- Exchange
- SCWO Nasdaq
- OSTX NYSE
- Market Cap
- SCWO 39.9M
- OSTX 43.0M
- IPO Year
- SCWO N/A
- OSTX 2024
- Fundamental
- Price
- SCWO $0.36
- OSTX $1.81
- Analyst Decision
- SCWO
- OSTX Strong Buy
- Analyst Count
- SCWO 0
- OSTX 3
- Target Price
- SCWO N/A
- OSTX $18.00
- AVG Volume (30 Days)
- SCWO 3.4M
- OSTX 301.8K
- Earning Date
- SCWO 08-13-2025
- OSTX 08-14-2025
- Dividend Yield
- SCWO N/A
- OSTX N/A
- EPS Growth
- SCWO N/A
- OSTX N/A
- EPS
- SCWO N/A
- OSTX N/A
- Revenue
- SCWO $673,267.00
- OSTX N/A
- Revenue This Year
- SCWO $5,945.19
- OSTX N/A
- Revenue Next Year
- SCWO $106.82
- OSTX N/A
- P/E Ratio
- SCWO N/A
- OSTX N/A
- Revenue Growth
- SCWO 161.19
- OSTX N/A
- 52 Week Low
- SCWO $0.25
- OSTX $1.12
- 52 Week High
- SCWO $1.99
- OSTX $7.00
- Technical
- Relative Strength Index (RSI)
- SCWO 47.09
- OSTX N/A
- Support Level
- SCWO $0.36
- OSTX N/A
- Resistance Level
- SCWO $0.42
- OSTX N/A
- Average True Range (ATR)
- SCWO 0.06
- OSTX 0.00
- MACD
- SCWO -0.01
- OSTX 0.00
- Stochastic Oscillator
- SCWO 1.63
- OSTX 0.00
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.